Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
October 1, 1997British Journal of Dermatology

A novel anti-inflammatory drug, SDZ ASM 981, for the topical and oral treatment of skin diseases:in vivopharmacology

View Full Paper
Ask AI
Bookmark
Share

Authors

JMJosef G. MeingassnerForschungs- und Beratungsstelle ArbeitsweltMGM. A. GrassbergerNovartis (Austria)HFHermann FahrngruberNovartis (Switzerland)

Discussion

Loading...

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

Meingassner et al. (1997) studied this question.

synapsesocial.com/papers/6a7bb723073f483584df888fhttps://doi.org/10.1111/j.1365-2133.1997.tb03788.x
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 2 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Clinical Controversy on the Effect of Topical Ciclosporin: What Is the Target Site?2009 · 20 citations
  2. 2A LYMPH NODE WEIGHT ASSAY FOR THE GRAFTVERSUS- HOST ACTIVITY OF RAT LYMPHOID CELLS1970 · 308 citations